⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Official Title: A Study of a Topical Formulation of Nitroglycerin, MQX-503, and Matching Vehicle in the Treatment and Prevention of Raynaud's Phenomenon

Study ID: NCT00577304

Study Description

Brief Summary: The purpose of this research study is to test the safety, tolerability, and effectiveness of Topical AmphiMatrix with Nitroglycerin (MQX0503) to relieve Raynaud's symptoms and increase blood flow to the fingers.

Detailed Description: The purpose of this clinical study is to determine, in a controlled fashion, the ability of a topical formulation of Nitroglycerin, MQX-503, to improve the patient's health assessment as indicated by patient and physician assessments, decrease the frequency of Raynaud's events, decrease the duration of Raynaud's events, and decrease the symptoms (pain, tingling, numbness) in the fingers of Raynaud's patients. The study will include patients with moderate to severe primary Raynaud's Phenomenon (RP) and with moderate to severe Raynaud's Phenomenon secondary to autoimmune diseases, such as scleroderma.

Eligibility

Minimum Age: 15 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Stanford University, Stanford, California, United States

University of Colorado Health Sciences Center, Denver, Colorado, United States

University of Connecticut, Farmington, Connecticut, United States

Georgetown University, Washington, District of Columbia, United States

University of Chicago, Chicago, Illinois, United States

Johns Hopkins University, Baltimore, Maryland, United States

Boston University, Boston, Massachusetts, United States

Arthritis Education and Treatment Center, PLLC, Grand Rapids, Michigan, United States

University of Minnesota, Minneapolis, Minnesota, United States

University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States

The Center for Rheumatology, Albany, New York, United States

SUNY Stony Brook, Stony Brook, New York, United States

Carolina Arthritis, Wilmington, North Carolina, United States

University of Toledo, Toledo, Ohio, United States

Medical University of South Carolina, Charleston, South Carolina, United States

University of Texas at Houston, Houston, Texas, United States

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Contact Details

Name: Jan Ohrstrom, PhD

Affiliation: MediQuest Therapeutics

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: